9.24
Finanzdaten der Integra Lifesciences Holdings Corp-Aktie (IART)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
8.17%
434.93
|
402.06 | 415.61 | 382.65 | 442.65 |
| Cost Of Revenue |
9.73%
214.06
|
195.07 | 206.27 | 188.22 | 193.57 |
| Gross Profit |
6.70%
220.87
|
206.99 | 209.33 | 194.43 | 249.07 |
|
|
1.33%
197.82
|
195.23 | 722.01 | 209.93 | 213.44 |
| Benefits Costs and Expenses |
5.31%
430.62
|
408.89 | 946.56 | 412.69 | 420.11 |
| Costs And Expenses |
5.53%
411.88
|
390.30 | 928.28 | 398.15 | 407.02 |
| Operating Income/Loss |
95.90%
23.04
|
11.76 | -512.67 | -15.50 | 35.63 |
| Income/Loss From Continuing Operations Before Tax |
163.16%
4.31
|
-6.824 | -530.95 | -30.04 | 22.54 |
| Income Tax Expense/Benefit, Deferred |
26.52%
-10.95
|
-8.653 | -44.83 | -1.832 | -6.988 |
| Income Tax Expense/Benefit |
523.52%
6.014
|
-1.42 | -46.88 | -4.743 | 3.106 |
| Income/Loss From Continuing Operations After Tax |
68.47%
-1.704
|
-5.404 | -484.07 | -25.29 | 19.43 |
|
|
68.47%
-1.704
|
-5.404 | -484.07 | -25.29 | 19.43 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.95%
0.035
|
76.75 | 76.69 | 76.46 | -0.186 |
| Diluted Average Shares |
99.95%
0.035
|
76.75 | 76.69 | 76.46 | -0.186 |
| Basic Earnings Per Share |
71.43%
-0.02
|
-0.07 | -6.31 | -0.33 | 0.25 |
| Diluted Earnings Per Share |
71.43%
-0.02
|
-0.07 | -6.31 | -0.33 | 0.25 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):